Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-19

Clinical Trial Update: Comparison of Sugammadex and Neostigmine During PACU Stay [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing sugammadex versus neostigmine during the post-anesthesia care unit stay for neuromuscular blockade reversal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine (neostigmine)
  • Sugammadex (sugammadex)

Snippet

Sponsor: University of South Florida | Conditions: Neuromuscular Blockade | Phase 3 | Status: NOT_YET_RECRUITING